Pharma Company And Drug Testing Industry Claim Trump’s Rescheduling Move Will ‘Increase Marijuana Abuse’
A drug testing industry association and a pharmaceutical company are asking a federal court to block the Trump administration from moving forward with federal cannabis rescheduling while ongoing litigation challenging the reform is considered—arguing that “marijuana abuse has dangerous, lifelong consequences—especially for adolescents and pregnant women.” The new filing claims that “by cutting taxes on […]
A U.S. Weed Company Finally Cracked The NYSE. It Had To Leave The Recreational Pot Behind.
The Door Opened In April A Second Green Rush. Maybe? Trulieve becomes the first U.S. cannabis company to trade on the NYSE on June 10. To get through the door, it carved the recreational weed out of the company entirely. Wall Street is letting in a U.S. weed company for the first time. Just not […]
Anti-Marijuana Groups And Pharma Company Ask Court To Revive Lawsuit Challenging Medicare Hemp Coverage Program
A coalition of anti-marijuana groups and a cannabis-focused biopharmaceutical corporation are asking a federal appeals court to overturn a judge’s dismissal of their lawsuit challenging a new Trump administration initiative to cover up to $500 worth of hemp-derived products each year for eligible Medicare patients. Last month, Judge Trevor N. McFadden dismissed the challenge to […]
Trump Is Being Sued For Rescheduling Marijuana By Doctors And A Pharmaceutical Company Who Are ‘Aggrieved’ By The Move
The Trump administration’s move to federally reschedule marijuana is being challenged with yet another lawsuit, and this one includes the president himself in the list of defendants. The latest litigation was filed by a coalition of anti-marijuana activists, substance misuse professionals, doctors and a cannabis-focused biopharmaceutical corporation. “The Final Order was issued without prior notice-and-comment […]